SIDI could be useful for NDIs
This article was originally published in The Tan Sheet
Executive Summary
FDA expects the Standardized Information on Dietary Ingredients program to be a "valuable tool" for collecting new dietary ingredient notification information, Council for Responsible Nutrition VP for Scientific and Regulatory Affairs Andrew Shao tells supplement industry executives at CRN's annual conference Oct. 4. FDA's Center for Food Safety and Applied Nutrition director of dietary supplement programs, Bill Frankos, told CRN it provides the "same type of information that FDA looks for in those notifications that they never get." In his presentation, Shao provided an overview of SIDI, a voluntary program established by supplement industry trade groups in October 2006 to simplify and standardize the exchange of information between ingredient suppliers and product manufacturers (1"The Tan Sheet" Oct. 23, 2006, p. 8). CFSAN Director Robert E. Brackett stated NDIs marketed without undergoing the NDI notification process is one of the agency's top concerns...
You may also be interested in...
SIDI Program Will Standardize Ingredient Protocol – Supplement Trade Groups
A voluntary protocol could prompt "a major paradigm shift for many in the [dietary supplement] industry by moving away from unique individualized questionnaires towards standardized documentation and information exchange," trade groups say
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.